Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

CNTBCNTB
13 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in CONNECT BIOPHARMA HLDGS LTD

No. RA Capital Management exited its CNTB (Connect Biopharma) position in Q1 2024. Its Q4 2023 13F listed 3,062,871 shares worth $3.6M. RA Capital Management first reported CNTB in Q1 2021 and held it in 12 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$55.3M

Total Shares Change

-3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%$1.74
0
2023-Q4
Decreased
3.1M
-56.2%
$3.6M0.1%$1.18
0
2023-Q3
Unchanged
7M
0.0%
$5.7M0.1%$0.82
0
2023-Q2
Unchanged
7M
0.0%
$7.9M0.1%$1.11
0
2023-Q1
Unchanged
7M
0.0%
$7M0.2%$0.91
0
2022-Q4
Unchanged
7M
0.0%
$6.1M0.1%$0.87
0
2022-Q3
Unchanged
7M
0.0%
$9M0.2%$1.22
0
2022-Q2
Unchanged
7M
0.0%
$6.1M0.2%$0.99
0
2022-Q1
Unchanged
7M
0.0%
$21.1M0.5%$3.16
0
2021-Q4
Unchanged
7M
0.0%
$36M0.6%$5.04
0
2021-Q3
Unchanged
7M
0.0%
$169.4M2.3%$23.09
0
2021-Q2
Increased
7M
+133.7%
$136.5M2.2%$19.48
84
2021-Q1
New
3M
-
$55.3M0.8%$16.32
57

Other major holders of CNTB: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used